SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyResearch in context

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyResearch in context

Summary: Background: The optimal timing for SARS-CoV-2 vaccines within the first year after allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We conducted a prospective, multicentre, observational study of allogeneic HCT recipients who initiated SARS-CoV-2 vaccinations w...

Full description

Bibliographic Details
Main Authors: Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V. Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir A. Toor, Stephanie Waldvogel, Lee M. Greenberger, Jeffery J. Auletta, Mary M. Horowitz, Marcie L. Riches, Miguel-Angel Perales
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:EClinicalMedicine
Subjects:
SARS-CoV-2
Covid-19
Vaccine
Transplant
Hematopoietic cell transplant
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023001608

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023001608

Similar Items